EWTX vs NAMS: stock comparison and AI forecast
Edgewise Therapeutics, Inc. (EWTX) and Newamsterdam Pharma Co N.V. (NAMS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
EWTX Edgewise Therapeutics, Inc.
- Price
- $38.11 +21.2% · 6M
- Market Cap
- $4.09B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
NAMS Newamsterdam Pharma Co N.V.
- Price
- $19.56 -34.5% · 6M
- Market Cap
- $2.38B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- EWTX is 1.7 times larger than NAMS by market capitalization ($4.09B against $2.38B).
- Over the last six months EWTX returned +21.2% and NAMS -34.5%.
- NAMS carries 0.12 times debt per unit of equity, against 0.07 times for EWTX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | EWTX | NAMS |
|---|---|---|
| Market Cap | $4.09B | $2.38B |
| P/B Ratio | 9.13x | 3.77x |
| EPS | $-1.82 | $-2.09 |
| Book Value/Share | $4.13 | $5.28 |
| Revenue/Share | – | $0.08 |
| FCF/Share | $-1.46 | $-1.20 |
Profitability & Margins
| Metric | EWTX | NAMS |
|---|---|---|
| ROE | -44.0% | -41.1% |
| ROA | -41.1% | -36.8% |
| ROIC | -48.6% | -38.7% |
| Operating Margin | – | -2420.1% |
| Net Margin | – | -2569.6% |
| EBT Margin | – | -2569.6% |
Financial Health
| Metric | EWTX | NAMS |
|---|---|---|
| Current Ratio | 16.24x | 9.03x |
| D/E Ratio | 0.07x | 0.12x |
| Financial Leverage | 1.07x | 1.12x |
| Working Capital | $442M | $586M |
Cash Flow
| Metric | EWTX | NAMS |
|---|---|---|
| Operating Cash Flow | -$158M | -$143M |
| Free Cash Flow | -$159M | -$144M |
| Capital Spending | -$550K | -$260K |
| FCF/Sales | – | -1423.1% |
| CapEx/Sales | – | 2.6% |
Operational Efficiency
| Metric | EWTX | NAMS |
|---|---|---|
| Asset Turnover | – | 0.01x |
| Fixed Assets Turnover | – | 24.6x |
Income Statement
| Metric | EWTX | NAMS |
|---|---|---|
| Total Revenue | – | $10M |
| Operating Income | -$219M | -$244M |
| Net Income | -$197M | -$260M |
| R&D Expense | $171M | $149M |
| SG&A Expense | – | $102M |
Dividend & Shareholder Information
| Metric | EWTX | NAMS |
|---|---|---|
| Shares Outstanding | 109M | 120M |
EWTX vs NAMS: stock comparison and AI forecast
Which is bigger, EWTX or NAMS?
EWTX is 1.7 times larger than NAMS by market capitalization ($4.09B against $2.38B).
Which stock performed better over the last six months, EWTX or NAMS?
Over the last six months EWTX returned +21.2% and NAMS -34.5%.
Which one does Intratio's AI model rank higher, EWTX or NAMS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.